Felbamate

How Hard Is It to Find Felbamate in Stock?

Felbamate is not in an active FDA shortage as of 2026, but it is consistently difficult to find at most retail pharmacies. The reason is structural: because felbamate is prescribed to only a small number of patients with severe, treatment-resistant epilepsy, most pharmacies have no incentive to keep it in regular stock. Drug retail stores and chains often don't carry it at all, and patients frequently need to call multiple locations or plan refills well in advance.

The best sources for felbamate are hospital and health-system pharmacies affiliated with neurology or epilepsy programs, specialty mail-order pharmacies, and retail chain locations that can place special orders through their wholesale distributors (typically arriving within 24–72 hours). Rural and suburban locations are least likely to have it on hand. Patients should plan refills 10–14 days in advance to account for possible ordering delays.

To avoid hours of phone calls, use medfinder to find felbamate in stock near you. medfinder contacts pharmacies in your area, checks their current inventory, and texts you the results—so you can go straight to the pharmacy that has it.

Who Can Prescribe Felbamate?

Felbamate is not a controlled substance and has no DEA prescribing restrictions. However, because it carries black box warnings for aplastic anemia and liver failure—and requires written patient consent and baseline laboratory monitoring before initiation—it is almost always prescribed by epilepsy specialists in practice.

Neurologists (especially epileptologists)

Pediatric neurologists (for Lennox-Gastaut syndrome)

Epilepsy center specialists at NAEC-accredited programs

Physicians and advanced practice providers (NPs/PAs) with epilepsy management experience

Telehealth is generally not appropriate for initiating felbamate, as baseline blood tests (CBC, liver function) and signed informed consent documentation must be coordinated in person. Established patients who are stable on felbamate may use telehealth for follow-up management visits between in-person appointments with their neurologist.

Is Felbamate a Controlled Substance?

No. Felbamate is not a controlled substance and has no DEA schedule. It can be prescribed by any licensed physician, nurse practitioner, or physician assistant with prescribing authority, without the special DEA registration requirements that apply to Schedule II–V drugs.

However, felbamate has a unique regulatory requirement that is stricter than most non-controlled medications: the prescribing physician must obtain a signed Patient/Physician Acknowledgment Form from the patient before the first prescription can be written. This form documents that the patient understands the serious risks of aplastic anemia and hepatic failure associated with felbamate. In practice, this means felbamate cannot be started without a specialist evaluation and proper informed consent—making it one of the most carefully regulated non-controlled drugs on the market.

There are no DEA refill restrictions on felbamate (unlike Schedule II drugs, which cannot be refilled). However, most insurance plans require prior authorization, and monitoring requirements mean that prescriptions are typically re-evaluated and renewed at regular specialist visits.

Common Side Effects of Felbamate

Common side effects reported during clinical trials and post-marketing include:

Anorexia (loss of appetite) and weight loss

Nausea and vomiting

Insomnia

Headache

Dizziness and somnolence (drowsiness)

Double vision (diplopia)

Changes in taste perception

Gait disturbance (coordination problems)

Serious Side Effects (Black Box Warnings)

Aplastic anemia: Life-threatening blood disorder; risk estimated at >100x the general population rate (27–207 cases/million patient-years). Seek care immediately for fever, unusual bleeding or bruising, extreme fatigue, or signs of infection.

Hepatic (liver) failure: ~6 cases per 75,000 patient-years; ~67% result in death or liver transplant. Seek immediate care for jaundice, dark urine, upper abdominal pain, or persistent nausea.

Suicidal thoughts and behaviors: Class warning for all antiepileptic drugs. Monitor for new or worsening depression or unusual mood changes.

Final Thoughts on Felbamate

Felbamate is one of the most carefully controlled non-scheduled medications in the United States. For the small population of patients with treatment-resistant epilepsy for whom it provides meaningful seizure control, it can be life-changing. Its unique dual mechanism—blocking NMDA receptors and enhancing GABA-A activity—targets pathways that other antiepileptic drugs don't, explaining why it works when other medications have failed.

The challenges for patients on felbamate are real: finding it at a pharmacy is harder than for most medications, it requires ongoing blood and liver monitoring, and its costs can be significant without coupon programs like GoodRx or SingleCare. Proactive refill management, a reliable specialty pharmacy relationship, and a knowledgeable neurologist who can manage its drug interactions are essential to staying safely on this medication long-term.

If you are struggling to find felbamate at a pharmacy near you, medfinder can help. Enter your medication, dosage, and location—medfinder contacts pharmacies near you to check current stock and texts you the results, saving you significant time and frustration.